Cai Lay Veterinary Pharmaceutical JSC (HNX: MKV)

HNX:MKV Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2019	Dec 31, 2018
Revenue	109,982	110,906	119,634	102,410	134,579
Revenue Growth (YoY)	-0.83%	-7.30%	16.82%	-23.90%	308.87%
Cost of Revenue	71,100	78,674	86,605	80,112	106,611
Gross Profit	38,882	32,232	33,029	22,298	27,967
Selling, General & Admin	26,751	21,539	21,086	14,185	21,187
Operating Expenses	26,751	21,539	21,086	14,185	21,187
Operating Income	12,131	10,693	11,942	8,113	6,780
Interest Expense	-38.53	-481.41	-1,182	-3,891	-4,920
Interest & Investment Income	465.96	298.02	247.49	1.04	10.79
Other Non Operating Income (Expenses)	-3,290	-2,757	-3,507	-1,721	-1,553
Pretax Income	9,268	7,752	7,502	2,502	318.07
Income Tax Expense	1,887	1,550	1,598	735.25	535.61
Net Income	7,382	6,201	5,904	1,767	-217.54
Net Income to Common	7,382	6,201	5,904	1,767	-217.54
Net Income Growth	19.03%	5.04%	234.10%	-	-
Shares Outstanding (Basic)	5	5	5	-	-
Shares Outstanding (Diluted)	5	5	5	-	-
Shares Change (YoY)	-0.00%	0.04%	-	-	-
EPS (Basic)	1476.00	1240.00	1181.00	-	-
EPS (Diluted)	1476.00	1240.00	1181.00	-	-
EPS Growth	19.03%	5.00%	-	-	-
Free Cash Flow	10,565	24,406	7,031	21,909	7,465
Free Cash Flow Per Share	2112.51	4880.09	1406.48	-	-
Gross Margin	35.35%	29.06%	27.61%	21.77%	20.78%
Operating Margin	11.03%	9.64%	9.98%	7.92%	5.04%
Profit Margin	6.71%	5.59%	4.94%	1.73%	-0.16%
Free Cash Flow Margin	9.61%	22.01%	5.88%	21.39%	5.55%
EBITDA	16,362	17,863	19,759	16,660	15,001
EBITDA Margin	14.88%	16.11%	16.52%	16.27%	11.15%
D&A For EBITDA	4,231	7,171	7,816	8,546	8,220
EBIT	12,131	10,693	11,942	8,113	6,780
EBIT Margin	11.03%	9.64%	9.98%	7.92%	5.04%
Effective Tax Rate	20.36%	20.00%	21.30%	29.38%	168.40%
Revenue as Reported	109,982	110,906	119,634	102,410	134,579

Source: S&P Capital IQ. Standard template. Financial Sources.